Abstract
Summary
Medical aesthetic regenerative injection is a kind of dermal filler with biostimulant materials as the main ingredient, which stimulates the regeneration of the body's own collagen to reshape, tighten, beautify and resist aging. According to the main components, it can be roughly divided into PLA, PCL, hydroxyapatite, PMMA, PVA, etc., among which PLA can be subdivided into PLLA and PDLLA.
The global Medical Aesthetic Regenerative Injections market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Medical Aesthetic Regenerative Injections Industry Forecast” looks at past sales and reviews total world Medical Aesthetic Regenerative Injections sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Aesthetic Regenerative Injections sales for 2024 through 2030. With Medical Aesthetic Regenerative Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Aesthetic Regenerative Injections industry.
This Insight Report provides a comprehensive analysis of the global Medical Aesthetic Regenerative Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Aesthetic Regenerative Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Aesthetic Regenerative Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Aesthetic Regenerative Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Aesthetic Regenerative Injections.
United States market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medical Aesthetic Regenerative Injections players cover Galderma, REGEN Biotech, Inc., Anteco Pharma, Merz Aesthetics, Sinclair, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Aesthetic Regenerative Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polylactic Acid (PLA)
Polycaprolactone (PCL)
Hydroxyapatite (CaHA)
Segmentation by Application:
Beauty Agency
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Galderma
REGEN Biotech, Inc.
Anteco Pharma
Merz Aesthetics
Sinclair
Changchun Shengboma Biological Materials
IMEIK
PRP Science
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Aesthetic Regenerative Injections market?
What factors are driving Medical Aesthetic Regenerative Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Aesthetic Regenerative Injections market opportunities vary by end market size?
How does Medical Aesthetic Regenerative Injections break out by Type, by Application?
The global Medical Aesthetic Regenerative Injections market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Medical Aesthetic Regenerative Injections Industry Forecast” looks at past sales and reviews total world Medical Aesthetic Regenerative Injections sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Aesthetic Regenerative Injections sales for 2024 through 2030. With Medical Aesthetic Regenerative Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Aesthetic Regenerative Injections industry.
This Insight Report provides a comprehensive analysis of the global Medical Aesthetic Regenerative Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Aesthetic Regenerative Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Aesthetic Regenerative Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Aesthetic Regenerative Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Aesthetic Regenerative Injections.
United States market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medical Aesthetic Regenerative Injections is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medical Aesthetic Regenerative Injections players cover Galderma, REGEN Biotech, Inc., Anteco Pharma, Merz Aesthetics, Sinclair, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Aesthetic Regenerative Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polylactic Acid (PLA)
Polycaprolactone (PCL)
Hydroxyapatite (CaHA)
Segmentation by Application:
Beauty Agency
Hospital
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Galderma
REGEN Biotech, Inc.
Anteco Pharma
Merz Aesthetics
Sinclair
Changchun Shengboma Biological Materials
IMEIK
PRP Science
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Aesthetic Regenerative Injections market?
What factors are driving Medical Aesthetic Regenerative Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Aesthetic Regenerative Injections market opportunities vary by end market size?
How does Medical Aesthetic Regenerative Injections break out by Type, by Application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Aesthetic Regenerative Injections Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Medical Aesthetic Regenerative Injections by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Medical Aesthetic Regenerative Injections by Country/Region, 2019, 2023 & 2030
2.2 Medical Aesthetic Regenerative Injections Segment by Type
2.2.1 Polylactic Acid (PLA)
2.2.2 Polycaprolactone (PCL)
2.2.3 Hydroxyapatite (CaHA)
2.3 Medical Aesthetic Regenerative Injections Sales by Type
2.3.1 Global Medical Aesthetic Regenerative Injections Sales Market Share by Type (2019-2024)
2.3.2 Global Medical Aesthetic Regenerative Injections Revenue and Market Share by Type (2019-2024)
2.3.3 Global Medical Aesthetic Regenerative Injections Sale Price by Type (2019-2024)
2.4 Medical Aesthetic Regenerative Injections Segment by Application
2.4.1 Beauty Agency
2.4.2 Hospital
2.4.3 Others
2.5 Medical Aesthetic Regenerative Injections Sales by Application
2.5.1 Global Medical Aesthetic Regenerative Injections Sale Market Share by Application (2019-2024)
2.5.2 Global Medical Aesthetic Regenerative Injections Revenue and Market Share by Application (2019-2024)
2.5.3 Global Medical Aesthetic Regenerative Injections Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Medical Aesthetic Regenerative Injections Breakdown Data by Company
3.1.1 Global Medical Aesthetic Regenerative Injections Annual Sales by Company (2019-2024)
3.1.2 Global Medical Aesthetic Regenerative Injections Sales Market Share by Company (2019-2024)
3.2 Global Medical Aesthetic Regenerative Injections Annual Revenue by Company (2019-2024)
3.2.1 Global Medical Aesthetic Regenerative Injections Revenue by Company (2019-2024)
3.2.2 Global Medical Aesthetic Regenerative Injections Revenue Market Share by Company (2019-2024)
3.3 Global Medical Aesthetic Regenerative Injections Sale Price by Company
3.4 Key Manufacturers Medical Aesthetic Regenerative Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Aesthetic Regenerative Injections Product Location Distribution
3.4.2 Players Medical Aesthetic Regenerative Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Medical Aesthetic Regenerative Injections by Geographic Region
4.1 World Historic Medical Aesthetic Regenerative Injections Market Size by Geographic Region (2019-2024)
4.1.1 Global Medical Aesthetic Regenerative Injections Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Medical Aesthetic Regenerative Injections Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Medical Aesthetic Regenerative Injections Market Size by Country/Region (2019-2024)
4.2.1 Global Medical Aesthetic Regenerative Injections Annual Sales by Country/Region (2019-2024)
4.2.2 Global Medical Aesthetic Regenerative Injections Annual Revenue by Country/Region (2019-2024)
4.3 Americas Medical Aesthetic Regenerative Injections Sales Growth
4.4 APAC Medical Aesthetic Regenerative Injections Sales Growth
4.5 Europe Medical Aesthetic Regenerative Injections Sales Growth
4.6 Middle East & Africa Medical Aesthetic Regenerative Injections Sales Growth
5 Americas
5.1 Americas Medical Aesthetic Regenerative Injections Sales by Country
5.1.1 Americas Medical Aesthetic Regenerative Injections Sales by Country (2019-2024)
5.1.2 Americas Medical Aesthetic Regenerative Injections Revenue by Country (2019-2024)
5.2 Americas Medical Aesthetic Regenerative Injections Sales by Type (2019-2024)
5.3 Americas Medical Aesthetic Regenerative Injections Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Aesthetic Regenerative Injections Sales by Region
6.1.1 APAC Medical Aesthetic Regenerative Injections Sales by Region (2019-2024)
6.1.2 APAC Medical Aesthetic Regenerative Injections Revenue by Region (2019-2024)
6.2 APAC Medical Aesthetic Regenerative Injections Sales by Type (2019-2024)
6.3 APAC Medical Aesthetic Regenerative Injections Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Aesthetic Regenerative Injections by Country
7.1.1 Europe Medical Aesthetic Regenerative Injections Sales by Country (2019-2024)
7.1.2 Europe Medical Aesthetic Regenerative Injections Revenue by Country (2019-2024)
7.2 Europe Medical Aesthetic Regenerative Injections Sales by Type (2019-2024)
7.3 Europe Medical Aesthetic Regenerative Injections Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Aesthetic Regenerative Injections by Country
8.1.1 Middle East & Africa Medical Aesthetic Regenerative Injections Sales by Country (2019-2024)
8.1.2 Middle East & Africa Medical Aesthetic Regenerative Injections Revenue by Country (2019-2024)
8.2 Middle East & Africa Medical Aesthetic Regenerative Injections Sales by Type (2019-2024)
8.3 Middle East & Africa Medical Aesthetic Regenerative Injections Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Aesthetic Regenerative Injections
10.3 Manufacturing Process Analysis of Medical Aesthetic Regenerative Injections
10.4 Industry Chain Structure of Medical Aesthetic Regenerative Injections
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Aesthetic Regenerative Injections Distributors
11.3 Medical Aesthetic Regenerative Injections Customer
12 World Forecast Review for Medical Aesthetic Regenerative Injections by Geographic Region
12.1 Global Medical Aesthetic Regenerative Injections Market Size Forecast by Region
12.1.1 Global Medical Aesthetic Regenerative Injections Forecast by Region (2025-2030)
12.1.2 Global Medical Aesthetic Regenerative Injections Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Medical Aesthetic Regenerative Injections Forecast by Type (2025-2030)
12.7 Global Medical Aesthetic Regenerative Injections Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Galderma
13.1.1 Galderma Company Information
13.1.2 Galderma Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.1.3 Galderma Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Galderma Main Business Overview
13.1.5 Galderma Latest Developments
13.2 REGEN Biotech, Inc.
13.2.1 REGEN Biotech, Inc. Company Information
13.2.2 REGEN Biotech, Inc. Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.2.3 REGEN Biotech, Inc. Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 REGEN Biotech, Inc. Main Business Overview
13.2.5 REGEN Biotech, Inc. Latest Developments
13.3 Anteco Pharma
13.3.1 Anteco Pharma Company Information
13.3.2 Anteco Pharma Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.3.3 Anteco Pharma Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Anteco Pharma Main Business Overview
13.3.5 Anteco Pharma Latest Developments
13.4 Merz Aesthetics
13.4.1 Merz Aesthetics Company Information
13.4.2 Merz Aesthetics Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.4.3 Merz Aesthetics Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merz Aesthetics Main Business Overview
13.4.5 Merz Aesthetics Latest Developments
13.5 Sinclair
13.5.1 Sinclair Company Information
13.5.2 Sinclair Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.5.3 Sinclair Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sinclair Main Business Overview
13.5.5 Sinclair Latest Developments
13.6 Changchun Shengboma Biological Materials
13.6.1 Changchun Shengboma Biological Materials Company Information
13.6.2 Changchun Shengboma Biological Materials Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.6.3 Changchun Shengboma Biological Materials Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Changchun Shengboma Biological Materials Main Business Overview
13.6.5 Changchun Shengboma Biological Materials Latest Developments
13.7 IMEIK
13.7.1 IMEIK Company Information
13.7.2 IMEIK Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.7.3 IMEIK Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 IMEIK Main Business Overview
13.7.5 IMEIK Latest Developments
13.8 PRP Science
13.8.1 PRP Science Company Information
13.8.2 PRP Science Medical Aesthetic Regenerative Injections Product Portfolios and Specifications
13.8.3 PRP Science Medical Aesthetic Regenerative Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 PRP Science Main Business Overview
13.8.5 PRP Science Latest Developments
14 Research Findings and Conclusion